Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Cancer biomarker). Showing records 1 – 30 of 240 total matches.

[1] [2] [3] [4] [5] [6] [7] [8]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters

1. Zhang, Dongyu. Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression.

Degree: 2014, Johns Hopkins University

 Purpose Serum prostate specific antigen (PSA) showed unfavorable accuracy to predict prostate cancer progression. With development of multidisciplinary medical science and impending need, the rate… (more)

Subjects/Keywords: prostate cancer; epidemiology; biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, D. (2014). Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37243

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zhang, Dongyu. “Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression.” 2014. Thesis, Johns Hopkins University. Accessed August 23, 2019. http://jhir.library.jhu.edu/handle/1774.2/37243.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zhang, Dongyu. “Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression.” 2014. Web. 23 Aug 2019.

Vancouver:

Zhang D. Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2019 Aug 23]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37243.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zhang D. Evaluation of Prostate Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer Progression. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37243

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Sydney

2. Lee, Aimei Yen-Jia. The glycoprotein Basigin in liver disease .

Degree: 2016, University of Sydney

 Basigin (Bsg) is a membrane glycoprotein expressed by many different cell types. Bsg is instrumental in tissue development, extracellular matrix (ECM) remodelling, and has been… (more)

Subjects/Keywords: liver; cancer; biomarker; glycosylation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, A. Y. (2016). The glycoprotein Basigin in liver disease . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/17163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lee, Aimei Yen-Jia. “The glycoprotein Basigin in liver disease .” 2016. Thesis, University of Sydney. Accessed August 23, 2019. http://hdl.handle.net/2123/17163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lee, Aimei Yen-Jia. “The glycoprotein Basigin in liver disease .” 2016. Web. 23 Aug 2019.

Vancouver:

Lee AY. The glycoprotein Basigin in liver disease . [Internet] [Thesis]. University of Sydney; 2016. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/2123/17163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lee AY. The glycoprotein Basigin in liver disease . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/17163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Victoria

3. Yu, Ting. Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors.

Degree: Dept. of Chemistry, 2013, University of Victoria

Cancer is a leading cause of death and some types of cancer are hard to diagnose at early stages. An accurate method for subtype classification… (more)

Subjects/Keywords: SPR sensor; Cancer; Biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yu, T. (2013). Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors. (Masters Thesis). University of Victoria. Retrieved from http://hdl.handle.net/1828/4661

Chicago Manual of Style (16th Edition):

Yu, Ting. “Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors.” 2013. Masters Thesis, University of Victoria. Accessed August 23, 2019. http://hdl.handle.net/1828/4661.

MLA Handbook (7th Edition):

Yu, Ting. “Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors.” 2013. Web. 23 Aug 2019.

Vancouver:

Yu T. Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors. [Internet] [Masters thesis]. University of Victoria; 2013. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/1828/4661.

Council of Science Editors:

Yu T. Detection of biomarkers for lung cancer and leukemia using SPR nanohole-based sensors. [Masters Thesis]. University of Victoria; 2013. Available from: http://hdl.handle.net/1828/4661


University of New South Wales

4. Masoumi Moghaddam, Samar. Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer.

Degree: Clinical School - St George Hospital, 2014, University of New South Wales

 Human epithelial ovarian cancer (EOC) is the leading cause of gynaecological cancer associated death. Most patients have advanced disease at diagnosis. Late presentation and widespread… (more)

Subjects/Keywords: Prognostic biomarker; Sprouty; Ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Masoumi Moghaddam, S. (2014). Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/54270 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13771/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Masoumi Moghaddam, Samar. “Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer.” 2014. Doctoral Dissertation, University of New South Wales. Accessed August 23, 2019. http://handle.unsw.edu.au/1959.4/54270 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13771/SOURCE02?view=true.

MLA Handbook (7th Edition):

Masoumi Moghaddam, Samar. “Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer.” 2014. Web. 23 Aug 2019.

Vancouver:

Masoumi Moghaddam S. Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer. [Internet] [Doctoral dissertation]. University of New South Wales; 2014. [cited 2019 Aug 23]. Available from: http://handle.unsw.edu.au/1959.4/54270 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13771/SOURCE02?view=true.

Council of Science Editors:

Masoumi Moghaddam S. Evaluation of the expression of Sprouty 1 protein and its clinical relevance in epithelial ovarian cancer. [Doctoral Dissertation]. University of New South Wales; 2014. Available from: http://handle.unsw.edu.au/1959.4/54270 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13771/SOURCE02?view=true


University of New South Wales

5. Millar, Ewan. Studies on biomarker development in breast cancer.

Degree: Garvan Institute of Medical Research, 2011, University of New South Wales

 Aim: To identify new prognostic and predictive biomarkers for clinical breast cancer, thereby improving patient selection for currently available therapies.Methods: Data derived from gene expression… (more)

Subjects/Keywords: Prognosis; Breast cancer; Biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Millar, E. (2011). Studies on biomarker development in breast cancer. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/51639 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10306/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Millar, Ewan. “Studies on biomarker development in breast cancer.” 2011. Doctoral Dissertation, University of New South Wales. Accessed August 23, 2019. http://handle.unsw.edu.au/1959.4/51639 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10306/SOURCE02?view=true.

MLA Handbook (7th Edition):

Millar, Ewan. “Studies on biomarker development in breast cancer.” 2011. Web. 23 Aug 2019.

Vancouver:

Millar E. Studies on biomarker development in breast cancer. [Internet] [Doctoral dissertation]. University of New South Wales; 2011. [cited 2019 Aug 23]. Available from: http://handle.unsw.edu.au/1959.4/51639 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10306/SOURCE02?view=true.

Council of Science Editors:

Millar E. Studies on biomarker development in breast cancer. [Doctoral Dissertation]. University of New South Wales; 2011. Available from: http://handle.unsw.edu.au/1959.4/51639 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10306/SOURCE02?view=true


Univerzitet u Beogradu

6. Sekulić, Aleksandar M., 1975-. Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu.

Degree: Medicinski fakultet, 2018, Univerzitet u Beogradu

Medicina - Hirurgija, Molekularna biologija / Medicine - Surgery, Molecular biology

Karcinom rektuma zbog visoke incidence i trenda njenog rasta u budućnosti, predstavlja veliki javnozdravstveni… (more)

Subjects/Keywords: rectal cancer; biomarker; prognosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sekulić, Aleksandar M., 1. (2018). Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:18646/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sekulić, Aleksandar M., 1975-. “Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu.” 2018. Thesis, Univerzitet u Beogradu. Accessed August 23, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:18646/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sekulić, Aleksandar M., 1975-. “Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu.” 2018. Web. 23 Aug 2019.

Vancouver:

Sekulić, Aleksandar M. 1. Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu. [Internet] [Thesis]. Univerzitet u Beogradu; 2018. [cited 2019 Aug 23]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:18646/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sekulić, Aleksandar M. 1. Prognostički značaj molekularnih markera, kliničkih i patohistoloških parametara kod bolesnika operisanih zbog karcinoma rektuma u ranom stadijumu. [Thesis]. Univerzitet u Beogradu; 2018. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:18646/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

7. Perez-Rogers, Joseph. Development of a minimally invasive molecular biomarker for early detection of lung cancer.

Degree: PhD, Bioinformatics GRS, 2017, Boston University

 The diagnostic evaluation of ever smokers with pulmonary nodules represents a growing clinical challenge due to the implementation of lung cancer screening. The high false-positive… (more)

Subjects/Keywords: Bioinformatics; Biomarker; Classifier; Lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Perez-Rogers, J. (2017). Development of a minimally invasive molecular biomarker for early detection of lung cancer. (Doctoral Dissertation). Boston University. Retrieved from http://hdl.handle.net/2144/21969

Chicago Manual of Style (16th Edition):

Perez-Rogers, Joseph. “Development of a minimally invasive molecular biomarker for early detection of lung cancer.” 2017. Doctoral Dissertation, Boston University. Accessed August 23, 2019. http://hdl.handle.net/2144/21969.

MLA Handbook (7th Edition):

Perez-Rogers, Joseph. “Development of a minimally invasive molecular biomarker for early detection of lung cancer.” 2017. Web. 23 Aug 2019.

Vancouver:

Perez-Rogers J. Development of a minimally invasive molecular biomarker for early detection of lung cancer. [Internet] [Doctoral dissertation]. Boston University; 2017. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/2144/21969.

Council of Science Editors:

Perez-Rogers J. Development of a minimally invasive molecular biomarker for early detection of lung cancer. [Doctoral Dissertation]. Boston University; 2017. Available from: http://hdl.handle.net/2144/21969


University of Adelaide

8. Chouhan, Hanumant Singh. [EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.

Degree: 2018, University of Adelaide

 Purpose The prognostic and predictive role of biomarkers in colorectal cancer is still being defined. The aim of this study was to determine the prognostic… (more)

Subjects/Keywords: BRAF; MSI; biomarker; colon cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chouhan, H. S. (2018). [EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/120400

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chouhan, Hanumant Singh. “[EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.” 2018. Thesis, University of Adelaide. Accessed August 23, 2019. http://hdl.handle.net/2440/120400.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chouhan, Hanumant Singh. “[EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.” 2018. Web. 23 Aug 2019.

Vancouver:

Chouhan HS. [EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer. [Internet] [Thesis]. University of Adelaide; 2018. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/2440/120400.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chouhan HS. [EMBARGOED] Prognostic and predictive value of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer. [Thesis]. University of Adelaide; 2018. Available from: http://hdl.handle.net/2440/120400

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Newcastle

9. Jankowski, Helen. Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles.

Degree: PhD, 2019, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Prostate cancer is one of the most commonly diagnosed cancers in Australia with excellent long-term survival rates. The… (more)

Subjects/Keywords: prostate cancer; biomarker; extracellular vesicles

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jankowski, H. (2019). Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1405557

Chicago Manual of Style (16th Edition):

Jankowski, Helen. “Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles.” 2019. Doctoral Dissertation, University of Newcastle. Accessed August 23, 2019. http://hdl.handle.net/1959.13/1405557.

MLA Handbook (7th Edition):

Jankowski, Helen. “Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles.” 2019. Web. 23 Aug 2019.

Vancouver:

Jankowski H. Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles. [Internet] [Doctoral dissertation]. University of Newcastle; 2019. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/1959.13/1405557.

Council of Science Editors:

Jankowski H. Identification of biomarkers and novel targets for prostate cancer from extracellular vesicles. [Doctoral Dissertation]. University of Newcastle; 2019. Available from: http://hdl.handle.net/1959.13/1405557


University of Toronto

10. Yao, Qian Li (Cindy). Methods for the Identification of Biomarkers in Prostate and Breast Cancer.

Degree: 2014, University of Toronto

Given the high incidence rate of both prostate cancer and breast cancer, it is crucial to identify early which individuals have cancer and moreover, which… (more)

Subjects/Keywords: biomarker; breast cancer; prostate cancer; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yao, Q. L. (. (2014). Methods for the Identification of Biomarkers in Prostate and Breast Cancer. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/94502

Chicago Manual of Style (16th Edition):

Yao, Qian Li (Cindy). “Methods for the Identification of Biomarkers in Prostate and Breast Cancer.” 2014. Masters Thesis, University of Toronto. Accessed August 23, 2019. http://hdl.handle.net/1807/94502.

MLA Handbook (7th Edition):

Yao, Qian Li (Cindy). “Methods for the Identification of Biomarkers in Prostate and Breast Cancer.” 2014. Web. 23 Aug 2019.

Vancouver:

Yao QL(. Methods for the Identification of Biomarkers in Prostate and Breast Cancer. [Internet] [Masters thesis]. University of Toronto; 2014. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/1807/94502.

Council of Science Editors:

Yao QL(. Methods for the Identification of Biomarkers in Prostate and Breast Cancer. [Masters Thesis]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/94502


University of Alberta

11. Chan, Angela W. Urinary Metabolomics of Gastric Cancer.

Degree: MS, School of Public Health, 2015, University of Alberta

 Gastric cancer is an aggressive malignancy. Much of the mortality is attributable to delayed diagnosis from non-specific symptoms, and lack of early and accurate screening… (more)

Subjects/Keywords: biomarker discovery; metabolomics; screening; gastric cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chan, A. W. (2015). Urinary Metabolomics of Gastric Cancer. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/6d5700510

Chicago Manual of Style (16th Edition):

Chan, Angela W. “Urinary Metabolomics of Gastric Cancer.” 2015. Masters Thesis, University of Alberta. Accessed August 23, 2019. https://era.library.ualberta.ca/files/6d5700510.

MLA Handbook (7th Edition):

Chan, Angela W. “Urinary Metabolomics of Gastric Cancer.” 2015. Web. 23 Aug 2019.

Vancouver:

Chan AW. Urinary Metabolomics of Gastric Cancer. [Internet] [Masters thesis]. University of Alberta; 2015. [cited 2019 Aug 23]. Available from: https://era.library.ualberta.ca/files/6d5700510.

Council of Science Editors:

Chan AW. Urinary Metabolomics of Gastric Cancer. [Masters Thesis]. University of Alberta; 2015. Available from: https://era.library.ualberta.ca/files/6d5700510


University of Illinois – Chicago

12. Mihelich, Brittany. MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer.

Degree: 2014, University of Illinois – Chicago

 This work examines the role of specific miRNAs in the molecular etiology of prostate cancer, their secretion from cells, and their application to blood-based biomarkers… (more)

Subjects/Keywords: miRNA; prostate; zinc; exosome; breast; cancer; biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mihelich, B. (2014). MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/18977

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mihelich, Brittany. “MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer.” 2014. Thesis, University of Illinois – Chicago. Accessed August 23, 2019. http://hdl.handle.net/10027/18977.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mihelich, Brittany. “MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer.” 2014. Web. 23 Aug 2019.

Vancouver:

Mihelich B. MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer. [Internet] [Thesis]. University of Illinois – Chicago; 2014. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/10027/18977.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mihelich B. MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer. [Thesis]. University of Illinois – Chicago; 2014. Available from: http://hdl.handle.net/10027/18977

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Otago

13. Coffey, Catherine Judith. Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 .

Degree: 2012, University of Otago

 Objective: This study discusses the need for a biomarker of regression of CIN 2 in women under 25, and aims to identify such a marker.… (more)

Subjects/Keywords: Cervical cancer screening; CIN 2; HPV; Biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Coffey, C. J. (2012). Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 . (Masters Thesis). University of Otago. Retrieved from http://hdl.handle.net/10523/2316

Chicago Manual of Style (16th Edition):

Coffey, Catherine Judith. “Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 .” 2012. Masters Thesis, University of Otago. Accessed August 23, 2019. http://hdl.handle.net/10523/2316.

MLA Handbook (7th Edition):

Coffey, Catherine Judith. “Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 .” 2012. Web. 23 Aug 2019.

Vancouver:

Coffey CJ. Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 . [Internet] [Masters thesis]. University of Otago; 2012. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/10523/2316.

Council of Science Editors:

Coffey CJ. Immunological and Biological Markers of Regression of CIN 2 in Women Under 25 . [Masters Thesis]. University of Otago; 2012. Available from: http://hdl.handle.net/10523/2316


University of the Western Cape

14. Khan, Firdous. Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach .

Degree: 2015, University of the Western Cape

 There are over 100 different types of cancer, and each of these cancers are classified by the type of cell that it initially affects. For… (more)

Subjects/Keywords: Prostate cancer; miRNA; Bioinformatics; Biomarker discovery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khan, F. (2015). Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/4746

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Khan, Firdous. “Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach .” 2015. Thesis, University of the Western Cape. Accessed August 23, 2019. http://hdl.handle.net/11394/4746.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Khan, Firdous. “Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach .” 2015. Web. 23 Aug 2019.

Vancouver:

Khan F. Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach . [Internet] [Thesis]. University of the Western Cape; 2015. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/11394/4746.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Khan F. Identification of miRNA's as specific biomarkers in prostate cancer diagnostics : a combined in silico and molecular approach . [Thesis]. University of the Western Cape; 2015. Available from: http://hdl.handle.net/11394/4746

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universitat de Valencia

15. Casanova Salas, Irene. Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention .

Degree: 2015, Universitat de Valencia

 El cáncer de próstata (CaP) es el segundo tumor más frecuente en hombres y la sexta causa de muerte por cáncer. Así pues, esta enfermedad… (more)

Subjects/Keywords: biomarker; personalized medicine; diagnosis; prognosis; prostate cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Casanova Salas, I. (2015). Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention . (Doctoral Dissertation). Universitat de Valencia. Retrieved from http://hdl.handle.net/10550/44486

Chicago Manual of Style (16th Edition):

Casanova Salas, Irene. “Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention .” 2015. Doctoral Dissertation, Universitat de Valencia. Accessed August 23, 2019. http://hdl.handle.net/10550/44486.

MLA Handbook (7th Edition):

Casanova Salas, Irene. “Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention .” 2015. Web. 23 Aug 2019.

Vancouver:

Casanova Salas I. Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention . [Internet] [Doctoral dissertation]. Universitat de Valencia; 2015. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/10550/44486.

Council of Science Editors:

Casanova Salas I. Defining new biotypes in Prostate Cancer for diagnosis, prognosis and therapeutic intervention . [Doctoral Dissertation]. Universitat de Valencia; 2015. Available from: http://hdl.handle.net/10550/44486

16. Oshita, Hideto. RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である.

Degree: 博士(医学), 2014, Hiroshima University / 広島大学

 Genome-wide gene expression profile analyses revealed that Ras and EF-hand domain containing (RASEF) was significantly transactivated in the majority of lung cancers. Transient expression of… (more)

Subjects/Keywords: oncogenes; cancer antigen; biomarker; therapeutic target; lungcancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oshita, H. (2014). RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である. (Thesis). Hiroshima University / 広島大学. Retrieved from http://ir.lib.hiroshima-u.ac.jp/00036269

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Oshita, Hideto. “RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である.” 2014. Thesis, Hiroshima University / 広島大学. Accessed August 23, 2019. http://ir.lib.hiroshima-u.ac.jp/00036269.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Oshita, Hideto. “RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である.” 2014. Web. 23 Aug 2019.

Vancouver:

Oshita H. RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である. [Internet] [Thesis]. Hiroshima University / 広島大学; 2014. [cited 2019 Aug 23]. Available from: http://ir.lib.hiroshima-u.ac.jp/00036269.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Oshita H. RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer : RASEFは肺癌の新たな診断マーカー及び治療標的である. [Thesis]. Hiroshima University / 広島大学; 2014. Available from: http://ir.lib.hiroshima-u.ac.jp/00036269

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Uppsala University

17. Lundberg, Martin. Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers.

Degree: Biology Education Centre, 2014, Uppsala University

  The Proximity Ligation Assay (PLA) is a relatively new method which utilizes the strength of both immunoassays and DNA detection. PLA has the capacity… (more)

Subjects/Keywords: PLA; colorectal cancer; biomarker; multiplex qPCR; Olink

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lundberg, M. (2014). Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-223943

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lundberg, Martin. “Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers.” 2014. Thesis, Uppsala University. Accessed August 23, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-223943.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lundberg, Martin. “Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers.” 2014. Web. 23 Aug 2019.

Vancouver:

Lundberg M. Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers. [Internet] [Thesis]. Uppsala University; 2014. [cited 2019 Aug 23]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-223943.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lundberg M. Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers. [Thesis]. Uppsala University; 2014. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-223943

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

18. Colvin, Emily Kate. Aberrations in embryonic signalling pathways in pancreatic cancer.

Degree: Garvan Institute of Medical Research, 2011, University of New South Wales

 Pancreatic cancer (PC) is the fourth leading cause of cancer death in western societies, with a 5-year survival rate of approximately 5%. There is an… (more)

Subjects/Keywords: Biomarker; Pancreatic Cancer; Retinoic Acid Signalling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Colvin, E. K. (2011). Aberrations in embryonic signalling pathways in pancreatic cancer. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/51452 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10138/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Colvin, Emily Kate. “Aberrations in embryonic signalling pathways in pancreatic cancer.” 2011. Doctoral Dissertation, University of New South Wales. Accessed August 23, 2019. http://handle.unsw.edu.au/1959.4/51452 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10138/SOURCE02?view=true.

MLA Handbook (7th Edition):

Colvin, Emily Kate. “Aberrations in embryonic signalling pathways in pancreatic cancer.” 2011. Web. 23 Aug 2019.

Vancouver:

Colvin EK. Aberrations in embryonic signalling pathways in pancreatic cancer. [Internet] [Doctoral dissertation]. University of New South Wales; 2011. [cited 2019 Aug 23]. Available from: http://handle.unsw.edu.au/1959.4/51452 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10138/SOURCE02?view=true.

Council of Science Editors:

Colvin EK. Aberrations in embryonic signalling pathways in pancreatic cancer. [Doctoral Dissertation]. University of New South Wales; 2011. Available from: http://handle.unsw.edu.au/1959.4/51452 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10138/SOURCE02?view=true


University of Windsor

19. Vacarescu, Rares Anthony. Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties.

Degree: MS, Physics, 2018, University of Windsor

 The human fingernail is a vital organ used by humans on a daily basis and can provide an immense supply of information based on the… (more)

Subjects/Keywords: acoustic; biomarker; cancer; fingernail; oncology; ultrasound

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vacarescu, R. A. (2018). Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties. (Masters Thesis). University of Windsor. Retrieved from https://scholar.uwindsor.ca/etd/7402

Chicago Manual of Style (16th Edition):

Vacarescu, Rares Anthony. “Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties.” 2018. Masters Thesis, University of Windsor. Accessed August 23, 2019. https://scholar.uwindsor.ca/etd/7402.

MLA Handbook (7th Edition):

Vacarescu, Rares Anthony. “Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties.” 2018. Web. 23 Aug 2019.

Vancouver:

Vacarescu RA. Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties. [Internet] [Masters thesis]. University of Windsor; 2018. [cited 2019 Aug 23]. Available from: https://scholar.uwindsor.ca/etd/7402.

Council of Science Editors:

Vacarescu RA. Development and Implementation of an Ultrasonic Method to Characterize Acoustic and Mechanical Fingernail Properties. [Masters Thesis]. University of Windsor; 2018. Available from: https://scholar.uwindsor.ca/etd/7402


University of Pennsylvania

20. Lynch, Shannon. Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer.

Degree: 2015, University of Pennsylvania

 Novel multidisciplinary and multilevel approaches are required to link biologic and social mechanisms with cancer. We propose a new biosocial concept, â??neighborhood cancerization,â?? which postulates… (more)

Subjects/Keywords: biomarker; cancer; neighborhood; social science; Epidemiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lynch, S. (2015). Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1092

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lynch, Shannon. “Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer.” 2015. Thesis, University of Pennsylvania. Accessed August 23, 2019. https://repository.upenn.edu/edissertations/1092.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lynch, Shannon. “Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer.” 2015. Web. 23 Aug 2019.

Vancouver:

Lynch S. Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer. [Internet] [Thesis]. University of Pennsylvania; 2015. [cited 2019 Aug 23]. Available from: https://repository.upenn.edu/edissertations/1092.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lynch S. Neighborhood Cancerization: New Approaches Linking Social and Biological Mechanisms of Cancer. [Thesis]. University of Pennsylvania; 2015. Available from: https://repository.upenn.edu/edissertations/1092

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

21. Gerrein, Joseph. Using gene and microRNA expression in the human airway for lung cancer diagnosis.

Degree: PhD, Bioinformatics, 2014, Boston University

 Lung cancer surpasses all other causes of cancer-related deaths worldwide. Gene-expression microarrays have shown that differences in the cytologically normal bronchial airway can distinguish between… (more)

Subjects/Keywords: Bioinformatics; Biomarker; Gene expression; Lung cancer; Nasal

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gerrein, J. (2014). Using gene and microRNA expression in the human airway for lung cancer diagnosis. (Doctoral Dissertation). Boston University. Retrieved from http://hdl.handle.net/2144/14145

Chicago Manual of Style (16th Edition):

Gerrein, Joseph. “Using gene and microRNA expression in the human airway for lung cancer diagnosis.” 2014. Doctoral Dissertation, Boston University. Accessed August 23, 2019. http://hdl.handle.net/2144/14145.

MLA Handbook (7th Edition):

Gerrein, Joseph. “Using gene and microRNA expression in the human airway for lung cancer diagnosis.” 2014. Web. 23 Aug 2019.

Vancouver:

Gerrein J. Using gene and microRNA expression in the human airway for lung cancer diagnosis. [Internet] [Doctoral dissertation]. Boston University; 2014. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/2144/14145.

Council of Science Editors:

Gerrein J. Using gene and microRNA expression in the human airway for lung cancer diagnosis. [Doctoral Dissertation]. Boston University; 2014. Available from: http://hdl.handle.net/2144/14145


Brigham Young University

22. Weagel, Evita Giraldez. Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies.

Degree: PhD, 2018, Brigham Young University

 Despite the global effort to discover and improve ways to detect, treat, and monitor cancer, it still remains the second leading cause of death in… (more)

Subjects/Keywords: thymidine kinase 1; TK1; cancer biomarker; Microbiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Weagel, E. G. (2018). Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies. (Doctoral Dissertation). Brigham Young University. Retrieved from https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=7881&context=etd

Chicago Manual of Style (16th Edition):

Weagel, Evita Giraldez. “Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies.” 2018. Doctoral Dissertation, Brigham Young University. Accessed August 23, 2019. https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=7881&context=etd.

MLA Handbook (7th Edition):

Weagel, Evita Giraldez. “Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies.” 2018. Web. 23 Aug 2019.

Vancouver:

Weagel EG. Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies. [Internet] [Doctoral dissertation]. Brigham Young University; 2018. [cited 2019 Aug 23]. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=7881&context=etd.

Council of Science Editors:

Weagel EG. Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies. [Doctoral Dissertation]. Brigham Young University; 2018. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=7881&context=etd


University of Southern California

23. Shah, Radhika. Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective.

Degree: MS, Biochemistry & Molecular Biology, 2009, University of Southern California

 The scope of breast cancer management has expanded ever since the discovery of several key biomarkers that could predict predisposition, toxicity and pharmacokinetic responses in… (more)

Subjects/Keywords: biomarker; 5-fluorouracil; breast cancer; business strategy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shah, R. (2009). Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/206271/rec/5006

Chicago Manual of Style (16th Edition):

Shah, Radhika. “Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective.” 2009. Masters Thesis, University of Southern California. Accessed August 23, 2019. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/206271/rec/5006.

MLA Handbook (7th Edition):

Shah, Radhika. “Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective.” 2009. Web. 23 Aug 2019.

Vancouver:

Shah R. Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective. [Internet] [Masters thesis]. University of Southern California; 2009. [cited 2019 Aug 23]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/206271/rec/5006.

Council of Science Editors:

Shah R. Personalized breast cancer management using 5-fluorouracil and related biomarkers: a molecular biology and business perspective. [Masters Thesis]. University of Southern California; 2009. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/206271/rec/5006

24. M'Rabet, Manel. Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies.

Degree: Docteur es, Pathologie humaine. Oncologie, 2017, Aix Marseille Université

Mes travaux de thèse ont permis d’identifier nectine-4 comme un nouveau biomarqueur, facteur de pronostic et cible thérapeutique dans 63% des cancers du sein triple-négatif… (more)

Subjects/Keywords: Cancer du sein; Marqueurs biologiques; Breast cancer; Biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

M'Rabet, M. (2017). Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2017AIXM0204

Chicago Manual of Style (16th Edition):

M'Rabet, Manel. “Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies.” 2017. Doctoral Dissertation, Aix Marseille Université. Accessed August 23, 2019. http://www.theses.fr/2017AIXM0204.

MLA Handbook (7th Edition):

M'Rabet, Manel. “Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies.” 2017. Web. 23 Aug 2019.

Vancouver:

M'Rabet M. Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies. [Internet] [Doctoral dissertation]. Aix Marseille Université 2017. [cited 2019 Aug 23]. Available from: http://www.theses.fr/2017AIXM0204.

Council of Science Editors:

M'Rabet M. Identification d'un nouveau biomarqueur, facteur pronostic et cible dans le cancer du sein triple négatif & développement préclinique d'une thérapie ciblée sur l'utilisation d'anticorps monoclonaux conjugués : Identification of a new biomarker, prognosis factor and target in triple negative breast cancer & pre-clinical development of targeted therapy based on conjugated monoclonal antibodies. [Doctoral Dissertation]. Aix Marseille Université 2017. Available from: http://www.theses.fr/2017AIXM0204


University of Plymouth

25. Bunting, David Mark. The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer.

Degree: PhD, 2016, University of Plymouth

 Introduction The prognosis in oesophago-gastric cancer is poor with less than 15% patients surviving beyond 5 years after diagnosis. The addition of neoadjuvant therapy has… (more)

Subjects/Keywords: 616.99; oesophageal cancer; gastric cancer; chemotherapy; chemoradiotherapy; biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bunting, D. M. (2016). The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer. (Doctoral Dissertation). University of Plymouth. Retrieved from http://hdl.handle.net/10026.1/6565

Chicago Manual of Style (16th Edition):

Bunting, David Mark. “The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer.” 2016. Doctoral Dissertation, University of Plymouth. Accessed August 23, 2019. http://hdl.handle.net/10026.1/6565.

MLA Handbook (7th Edition):

Bunting, David Mark. “The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer.” 2016. Web. 23 Aug 2019.

Vancouver:

Bunting DM. The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer. [Internet] [Doctoral dissertation]. University of Plymouth; 2016. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/10026.1/6565.

Council of Science Editors:

Bunting DM. The performance of circulating biomarkers in the prediction of response to neoadjuvant therapy in patients with oesophago-gastric cancer. [Doctoral Dissertation]. University of Plymouth; 2016. Available from: http://hdl.handle.net/10026.1/6565

26. Smutna, Veronika. Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2016, Paris Saclay

Le cancer du sein est l’un des cancers le plus souvent diagnostiqué chez les femmes en Europe et dans le monde. Pour certaines formes agressives… (more)

Subjects/Keywords: Biomarqueur; Cancer du sein; Métabolisme; Biomarker; Breast cancer; Metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smutna, V. (2016). Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer. (Doctoral Dissertation). Paris Saclay. Retrieved from http://www.theses.fr/2016SACLS159

Chicago Manual of Style (16th Edition):

Smutna, Veronika. “Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer.” 2016. Doctoral Dissertation, Paris Saclay. Accessed August 23, 2019. http://www.theses.fr/2016SACLS159.

MLA Handbook (7th Edition):

Smutna, Veronika. “Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer.” 2016. Web. 23 Aug 2019.

Vancouver:

Smutna V. Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer. [Internet] [Doctoral dissertation]. Paris Saclay; 2016. [cited 2019 Aug 23]. Available from: http://www.theses.fr/2016SACLS159.

Council of Science Editors:

Smutna V. Etudes génomiques haut débit pour la découverte de biomarqueurs dans le cancer du sein : High-Throughput Genomics for Biomarker Discovery in Breast Cancer. [Doctoral Dissertation]. Paris Saclay; 2016. Available from: http://www.theses.fr/2016SACLS159


Macquarie University

27. Mahboob, Sadia. Plasma proteomics for detection of early stage colorectal cancer biosignatures.

Degree: 2015, Macquarie University

Thesis by publication.

Bibliography: pages 252-267.

Chapter 1. Introduction  – Chapter 2. General materials and methods  – Chapter 3. Isolation of comprehensive human plasma peptidomes… (more)

Subjects/Keywords: Colon (Anatomy)  – Cancer  – Diagnosis; Rectum  – Cancer  – Diagnosis; Proteomics; colorectal cancer; plama; proteomics; biomarker

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mahboob, S. (2015). Plasma proteomics for detection of early stage colorectal cancer biosignatures. (Doctoral Dissertation). Macquarie University. Retrieved from http://hdl.handle.net/1959.14/1075157

Chicago Manual of Style (16th Edition):

Mahboob, Sadia. “Plasma proteomics for detection of early stage colorectal cancer biosignatures.” 2015. Doctoral Dissertation, Macquarie University. Accessed August 23, 2019. http://hdl.handle.net/1959.14/1075157.

MLA Handbook (7th Edition):

Mahboob, Sadia. “Plasma proteomics for detection of early stage colorectal cancer biosignatures.” 2015. Web. 23 Aug 2019.

Vancouver:

Mahboob S. Plasma proteomics for detection of early stage colorectal cancer biosignatures. [Internet] [Doctoral dissertation]. Macquarie University; 2015. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/1959.14/1075157.

Council of Science Editors:

Mahboob S. Plasma proteomics for detection of early stage colorectal cancer biosignatures. [Doctoral Dissertation]. Macquarie University; 2015. Available from: http://hdl.handle.net/1959.14/1075157


University of Washington

28. Baker, Kathryn Terese. Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing.

Degree: PhD, 2019, University of Washington

 Humans have attempted to fight cancer since the beginning of recorded history, but advances in the early detection of cancer have begun to emerge only… (more)

Subjects/Keywords: biomarker; colorectal cancer; early cancer detection; ovarian cancer; precancer; ulcerative colitis; Pathology; Molecular biology; Pathology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baker, K. T. (2019). Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing. (Doctoral Dissertation). University of Washington. Retrieved from http://hdl.handle.net/1773/43436

Chicago Manual of Style (16th Edition):

Baker, Kathryn Terese. “Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing.” 2019. Doctoral Dissertation, University of Washington. Accessed August 23, 2019. http://hdl.handle.net/1773/43436.

MLA Handbook (7th Edition):

Baker, Kathryn Terese. “Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing.” 2019. Web. 23 Aug 2019.

Vancouver:

Baker KT. Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing. [Internet] [Doctoral dissertation]. University of Washington; 2019. [cited 2019 Aug 23]. Available from: http://hdl.handle.net/1773/43436.

Council of Science Editors:

Baker KT. Characterization of Precancerous Mutations in Ulcerative-Colitis Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing. [Doctoral Dissertation]. University of Washington; 2019. Available from: http://hdl.handle.net/1773/43436

29. Rideau, Alexis. Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background.

Degree: Docteur es, Biologie cellulaire, 2017, Angers

De par leur incidence et un diagnostic tardif, les cancers du sein et du colon restent parmi les plus meurtriers en France. L’identification de marqueur… (more)

Subjects/Keywords: Olfm4; Biomarqueur; Cellule souche cancéreuse; Cancer du sein; Cancer colorectal; Olfm4; Biomarker; Cancer stem cell; Breast cancer; Colorectal cancer; 616.99; 611.018

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rideau, A. (2017). Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background. (Doctoral Dissertation). Angers. Retrieved from http://www.theses.fr/2017ANGE0071

Chicago Manual of Style (16th Edition):

Rideau, Alexis. “Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background.” 2017. Doctoral Dissertation, Angers. Accessed August 23, 2019. http://www.theses.fr/2017ANGE0071.

MLA Handbook (7th Edition):

Rideau, Alexis. “Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background.” 2017. Web. 23 Aug 2019.

Vancouver:

Rideau A. Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background. [Internet] [Doctoral dissertation]. Angers; 2017. [cited 2019 Aug 23]. Available from: http://www.theses.fr/2017ANGE0071.

Council of Science Editors:

Rideau A. Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire : Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background. [Doctoral Dissertation]. Angers; 2017. Available from: http://www.theses.fr/2017ANGE0071


Temple University

30. Kotredes, Kevin Patrick. Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression.

Degree: PhD, 2015, Temple University

Molecular Biology and Genetics

The isocitrate dehydrogenase (IDH) family of enzymes is central to cellular metabolism, catalyzing the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG)… (more)

Subjects/Keywords: Molecular biology; Genetics; Biochemistry;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kotredes, K. P. (2015). Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,356693

Chicago Manual of Style (16th Edition):

Kotredes, Kevin Patrick. “Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression.” 2015. Doctoral Dissertation, Temple University. Accessed August 23, 2019. http://digital.library.temple.edu/u?/p245801coll10,356693.

MLA Handbook (7th Edition):

Kotredes, Kevin Patrick. “Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression.” 2015. Web. 23 Aug 2019.

Vancouver:

Kotredes KP. Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression. [Internet] [Doctoral dissertation]. Temple University; 2015. [cited 2019 Aug 23]. Available from: http://digital.library.temple.edu/u?/p245801coll10,356693.

Council of Science Editors:

Kotredes KP. Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression. [Doctoral Dissertation]. Temple University; 2015. Available from: http://digital.library.temple.edu/u?/p245801coll10,356693

[1] [2] [3] [4] [5] [6] [7] [8]

.